American Heart Journal
Volume 154, Issue 2 , Pages 267-277 , August 2007

The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: A propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database

  • Maria Rosa Costanzo, MD, FACC

      Affiliations

    • Midwest Heart Foundation, Lombard, IL
    • Corresponding Author InformationReprint requests: Maria Rosa Costanzo, MD, FACC, Edward Hospital Center for Advanced Heart Failure, Midwest Heart Specialists, 801 South Washington Street, PO Box 3226, Naperville, IL 60566.
    • ,
  • R.S. Johannes, MD, MS

      Affiliations

    • Cardinal Health Clinical Research Group, Marlborough, MA
    • Brigham and Women's Hospital, Harvard Medical School, Boston, MA
    • ,
  • Michael Pine, MD, MBA, FACC

      Affiliations

    • Michael Pine and Associates, Inc, Chicago, IL
    • The University of Chicago, Chicago, IL
    • ,
  • Vikas Gupta, PharmD, BCPS

      Affiliations

    • Cardinal Health Clinical Research Group, Marlborough, MA
    • ,
  • Mitchell Saltzberg, MD, FACC

      Affiliations

    • Midwest Heart Foundation, Lombard, IL
    • ,
  • Joel Hay, PhD

      Affiliations

    • Pharmaceutical Economics and Policy, University of Southern California School of Pharmacy, Los Angeles, CA
    • ,
  • Clyde W. Yancy, MD, FACC

      Affiliations

    • Baylor Heart and Vascular Institute, Dallas, TX
    • ,
  • Gregg C. Fonarow, MD, FACC

      Affiliations

    • Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, Los Angeles, CA

Received 30 October 2006 ,Accepted 16 April 2007.

References 

  1. Redfield MM. Heart failure—an epidemic of uncertain proportions. N Engl J Med. 2005;347:1442–1444
  2. American Heart Association . Heart disease and stroke statistics—2003 update. Dallas, Tex: American Heart Association; 2002;
  3. Haldeman GA, Croft JB, Giles WH, et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985-1995. Am Heart J. 1999;137:352–360
  4. Adams KF, Lindenfeld J, Arnold JMO, et al. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12:10–38
  5. Ray WA. Observational studies of drugs and mortality. N Engl J Med. 2005;353:2319
  6. Vlahakes JG. The value of phase 4 clinical testing. N Engl J Med. 2006;354:413
  7. Ferguson TB. Aprotinin—are there lessons learned?. JAMA. 2007;297:527
  8. Hunter D. First, gather the data. N Engl J Med. 2006;354:329–331
  9. Hay J. Appropriate econometric methods for pharmacoeconometric studies of retrospective claims data. J Manag Care Pharm. 2005;11:344–348
  10. D'Agostino RB, D'Agostino RB. Estimating treatment effects using observational data. JAMA. 2007;297:314
  11. Adams KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209–216
  12. Heidenreich PA, Fonarow GC. Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure study with those from national and community cohorts. Am Heart J. 2006;152:935–939
  13. Abraham WT, Adams KF, Fonanow GC, et al. for the ADHERE Scientific Advisory Committee and Investigators and the ADHERE Study Group Inpatient mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) registry. J Am Coll Cardiol. 2005;46:57–64
  14. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of WRF with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487–1491
  15. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of WRF in congestive heart failure. J Card Fail. 2002;8:136–141
  16. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for a change?. J Am Soc Nephrol. 2003;14:2178–2187
  17. Seeger JD, Williams PL, Walker AM. An application of propensity score matching using claims data. Pharmacoepidemiol Drug Res. 2005;14:465–476
  18. Silber JH, Rosenbaum PR, Trudeau ME, et al. Multivariate matching and bias reduction in the surgical outcomes study. Med Care. 2001;39:1048–1064
  19. D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–2281
  20. Hirano K, Imbens GW. Estimation of causal effects using propensity score weighting: an application to data on right heart catheterization. Health Serv Outcomes Res Methodol. 2001;2:259–278
  21. Marcus SM, Gibbons RD. Estimating the efficacy of receiving treatment in randomized clinical trials with noncompliance. Health Serv Outcomes Res. 2001;2:247–258
  22. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using sub-classification on the propensity score. J Am Stat Assoc. 1984;79:516–524
  23. Parsons LS. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the Twenty-sixth Annual SAS® Users Group International Conference. Cary, (NC): SAS Institute Inc; 2001;p. 214–226
  24. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994;272:859–866
  25. Posner MA, Ash AS, Freund KM, et al. Comparing standard regression, propensity score matching, and instrumental variables methods for determining the influence of mammography on stage of diagnosis. Health Serv Outcomes Res Methodol. 2001;2:279–290
  26. Cuffe MS, Califf RM, Adams KF, et al. Short term intravenous milrinone for acute exacerbation of chronic heart failure. JAMA. 2002;287:1541–1547
  27. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated CHF: the PRECEDENT study. Am J Heart. 2002;144:1102–1108
  28. Elkayam U, Tasissa G, Binanay C, et al. Use and impact of inotropes and vasodilator therapy during heart failure hospitalization in the ESCAPE trial. Circ. 2004;110(17, Suppl 3):III515
  29. Dakak N, Makhoul N, Merdler A, et al. Haemodynamic and neurohumoral effects of flosequinan in severe heart failure: similarities and differences compared with intravenous nitroglycerin therapy. Eur J Heart. 1993;14:836–844
  30. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:1116–1143
  31. Butler J, Forman DE, Abraham WT, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J. 2004;147:331–338
  32. Jensen KT, Eiskjaer H, Carstens J, et al. Renal effects of brain natriuretic peptide in patients with congestive heart failure. Clin Sci. 1999;96:5–15
  33. Rayburn BK, Bourge RC. Nesiritide: a unique therapeutic cardiac peptide. Rev Cardiovasc Med. 2001;2(Suppl 2):S25–S31
  34. Appel RG, Wang J, Simonson MS, et al. A mechanism by which atrial natriuretic factor mediates its glomerular actions. Am J Physiol. 1986;251:F1036–F1042
  35. Holmes SJ, Espiner EA, Richards AM, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76:91–96
  36. Mentzer RM, Oz MC, Sladen RN, et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial. J Am Coll Cardiol. 2007;49:716–726
  37. Cataliotti A, Boerrigter G, Costello-Boerrigter LC, et al. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation. 2004;109:1680–1685
  38. Scios selects Duke Clinical Research Institute (DCRI) to lead landmark international outcomes trial of NATRECOR (nesiritide), September 6, 2006 . Available at www.sciosinc.com[accessed February 28, 2007]

 Dr Costanzo, Dr Saltzberg, Dr Yancy, and Dr Fonarow have received honoraria and have served as consultants for Scios Inc. Dr Gupta has received honoraria from Scios Inc, Mountain View, CA. Dr Hay has served as a consultant to Scios Inc. The Acutely Decompensated Heart Failure National Registry (ADHERE) and this study were funded by Scios Inc. Access to the ADHERE database was provided by the Scientific Advisory Committee for ADHERE. The investigators designed and executed the analysis and prepared this manuscript independent of the sponsor, Scios Inc. The sponsor reviewed the results of the analysis and the manuscript. However, neither results nor manuscript were altered as a consequence of the sponsor's review.

 Dr Costanzo had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The study concept and design were by Costanzo, Johannes, Pine, Gupta, Hay, Fonarow, and Yancy. Acquisition of data was done by Johannes, Pine, and Gupta; analysis and interpretation of data by Costanzo, Johannes, Pine, Gupta, Saltzberg, Hay, Yancy, and Fonarow; drafting of the manuscript by Costanzo, Johannes, Pine, and Gupta; critical revision of the manuscript for important intellectual content by Costanzo, Johannes, Pine, Gupta, Saltzberg, Hay, Yancy, and Fonarow. Statistical expertise was provided by Johannes, Pine, and Hay; funding obtained by Johannes and Gupta; and administrative, technical, or material support obtained by Johannes, Pine, Gupta, and Hay. Study supervision was done by Johannes, Pine, and Gupta.

PII: S0002-8703(07)00357-2

doi: 10.1016/j.ahj.2007.04.033

American Heart Journal
Volume 154, Issue 2 , Pages 267-277 , August 2007

Article Tools

* Image Usage & Resolution